Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Queensland Health
Express Scripts
Boehringer Ingelheim
Fuji
Federal Trade Commission
Chinese Patent Office
Daiichi Sankyo
Moodys
Cipla

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090038

« Back to Dashboard

NDA 090038 describes MILRINONE LACTATE IN PLASTIC CONTAINER, which is a drug marketed by Hikma Farmaceutica and is included in one NDA. It is available from one supplier. Additional details are available on the MILRINONE LACTATE IN PLASTIC CONTAINER profile page.

The generic ingredient in MILRINONE LACTATE IN PLASTIC CONTAINER is milrinone lactate. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.
Summary for 090038
Tradename:MILRINONE LACTATE IN PLASTIC CONTAINER
Applicant:Hikma Farmaceutica
Ingredient:milrinone lactate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 090038
Suppliers and Packaging for NDA: 090038
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MILRINONE LACTATE IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 090038 ANDA West-Ward Pharmaceuticals Corp 0143-9718 N 0143-9718-10
MILRINONE LACTATE IN PLASTIC CONTAINER milrinone lactate INJECTABLE;INJECTION 090038 ANDA West-Ward Pharmaceuticals Corp 0143-9719 N 0143-9719-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 20MG BASE/100ML (EQ 0.2MG BASE/ML)
Approval Date:Jan 21, 2010TE:APRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 40MG BASE/200ML (EQ 0.2MG BASE/ML)
Approval Date:Jan 21, 2010TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
AstraZeneca
QuintilesIMS
US Department of Justice
Baxter
Dow
Cipla
Citi
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot